{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicj6xq44vzorta5s7pgirgpvwla2ipqo4oyvh6owkbiz6pjolkx24",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlvaynynthi2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieqha43nos4ahzyw7z7kvo6p6wfgjwjlmsmo44hyazyuxl3szioba"
    },
    "mimeType": "image/jpeg",
    "size": 303555
  },
  "path": "/news/2026-05-links-obesity-drugs-reduction-asthma.html",
  "publishedAt": "2026-05-15T06:42:21.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "New research presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows the use of the new GLP-1 class of obesity drugs in people with asthma is associated with a 26% fall in the number of asthma exacerbations and a 14% drop in use of asthma inhaler reliever use.",
  "title": "Study links use of new obesity drugs to reduction of asthma exacerbations and inhaler use"
}